Atlas Trials

Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer

Clinical trial NCT03920488 · UNKNOWN

Trial details

NCT number
NCT03920488
Sponsor
European Institute of Oncology
Status
UNKNOWN
Study type
OBSERVATIONAL
Triple Negative Breast Cancer
Start date
2018-06-01
Primary completion
2023-12-31
Enrollment
264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.